Hydro Invests in Flexible Thin Film Solar Cell Manufacturer

Hydro has entered into a securities purchase agreement with U.S. solar energy company Ascent Solar Technologies, Inc. Hydro's investment in common stock of Ascent Solar will be USD 5 million.

FLEXIBLE: Solar modules made by Ascent Solar.

The private placement is subject to, and is expected to be completed at the same time as, an underwritten public offering of Ascent Solar common stock, which is expected to close on October 6.

The capital injection into Ascent Solar, which makes flexible thin-film solar modules, is intended to enable the company to ramp up its 30-megawatt thin-film production facility in Thornton, Colorado, in 2010.

Hydro currently owns approximately 35 percent of Ascent Solar's common stock and will remain the largest shareholder immediately after the private placement.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hydro - Aluminium Alloys and Products. (2019, February 10). Hydro Invests in Flexible Thin Film Solar Cell Manufacturer. AZoM. Retrieved on April 26, 2024 from https://www.azom.com/news.aspx?newsID=19161.

  • MLA

    Hydro - Aluminium Alloys and Products. "Hydro Invests in Flexible Thin Film Solar Cell Manufacturer". AZoM. 26 April 2024. <https://www.azom.com/news.aspx?newsID=19161>.

  • Chicago

    Hydro - Aluminium Alloys and Products. "Hydro Invests in Flexible Thin Film Solar Cell Manufacturer". AZoM. https://www.azom.com/news.aspx?newsID=19161. (accessed April 26, 2024).

  • Harvard

    Hydro - Aluminium Alloys and Products. 2019. Hydro Invests in Flexible Thin Film Solar Cell Manufacturer. AZoM, viewed 26 April 2024, https://www.azom.com/news.aspx?newsID=19161.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.